Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (548)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
145
2024
2910
9.380
Why?
Hematopoietic Stem Cell Transplantation
27
2024
553
3.660
Why?
Pyrazines
20
2023
187
2.790
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
987
2.630
Why?
Boronic Acids
19
2014
182
2.580
Why?
Thalidomide
28
2023
374
2.550
Why?
Antineoplastic Agents
30
2020
1172
2.040
Why?
Transplantation, Autologous
29
2024
456
1.870
Why?
Drug Resistance, Neoplasm
17
2020
308
1.550
Why?
Transplantation Conditioning
9
2019
83
1.550
Why?
Paraproteinemias
8
2018
72
1.340
Why?
Neoplastic Stem Cells
5
2020
103
1.230
Why?
Humans
155
2024
49826
1.230
Why?
Protease Inhibitors
6
2011
58
1.130
Why?
Venous Thrombosis
7
2009
91
1.090
Why?
Melphalan
16
2023
174
1.050
Why?
Stem Cell Transplantation
13
2023
181
1.050
Why?
Angiogenesis Inhibitors
9
2009
187
1.030
Why?
Aged
57
2023
9272
0.990
Why?
Gene Expression Regulation, Neoplastic
13
2020
829
0.980
Why?
Hematopoietic Stem Cell Mobilization
5
2014
57
0.980
Why?
Prognosis
33
2024
1951
0.970
Why?
Middle Aged
59
2023
11997
0.930
Why?
Alkaline Phosphatase
5
2011
94
0.890
Why?
Busulfan
3
2019
18
0.890
Why?
Treatment Outcome
39
2022
5138
0.830
Why?
Plasma Cells
11
2023
223
0.810
Why?
Dexamethasone
16
2024
429
0.780
Why?
Male
66
2021
25092
0.710
Why?
Chromosome Aberrations
9
2008
298
0.690
Why?
Thromboembolism
3
2009
54
0.690
Why?
Female
62
2021
26327
0.660
Why?
Neoplasm Proteins
6
2021
323
0.660
Why?
Chromosomes, Human, Pair 13
6
2008
38
0.630
Why?
Disease-Free Survival
14
2019
457
0.600
Why?
Immunoglobulin Light Chains
3
2016
81
0.600
Why?
Survival Rate
18
2019
904
0.590
Why?
Bone Remodeling
2
2010
149
0.590
Why?
Anticoagulants
5
2009
254
0.590
Why?
Gene Expression Profiling
18
2023
1031
0.580
Why?
Blood Transfusion
1
2018
121
0.580
Why?
Immunologic Factors
5
2012
114
0.580
Why?
Cell Line, Tumor
18
2023
1402
0.550
Why?
Follow-Up Studies
21
2024
2178
0.540
Why?
Receptors, Retinoic Acid
2
2013
23
0.540
Why?
Antineoplastic Agents, Alkylating
7
2008
74
0.530
Why?
Proteasome Inhibitors
6
2018
104
0.530
Why?
IMP Dehydrogenase
2
2006
3
0.530
Why?
Mycophenolic Acid
2
2006
18
0.520
Why?
Clinical Trials as Topic
9
2022
460
0.520
Why?
Combined Modality Therapy
13
2008
636
0.500
Why?
Adult
37
2018
13159
0.500
Why?
Recurrence
16
2018
651
0.490
Why?
Cell Proliferation
15
2020
1007
0.490
Why?
Antigens, Neoplasm
5
2007
151
0.480
Why?
Apoptosis
9
2019
1100
0.480
Why?
Up-Regulation
5
2020
450
0.470
Why?
Antibodies, Monoclonal
3
2015
458
0.470
Why?
Osteogenesis
3
2012
351
0.460
Why?
Retrospective Studies
18
2024
6116
0.460
Why?
Animals
30
2024
13149
0.460
Why?
Venous Thromboembolism
3
2011
71
0.460
Why?
Survival Analysis
12
2021
659
0.450
Why?
Doxorubicin
8
2018
229
0.450
Why?
Disease Progression
12
2019
822
0.450
Why?
Signal Transduction
12
2020
1617
0.450
Why?
Bone Diseases
3
2012
98
0.430
Why?
Thrombosis
4
2012
249
0.420
Why?
Central Nervous System Neoplasms
2
2004
63
0.420
Why?
T-Lymphocytes
10
2024
338
0.410
Why?
Myeloablative Agonists
5
2014
30
0.410
Why?
Bone Marrow
7
2022
362
0.400
Why?
Transplantation, Homologous
6
2004
138
0.400
Why?
Oligopeptides
2
2013
89
0.400
Why?
Osteoblasts
4
2007
449
0.390
Why?
Risk Factors
18
2018
3619
0.390
Why?
Hematopoietic Stem Cells
2
2010
184
0.390
Why?
Meta-Analysis as Topic
2
2015
40
0.370
Why?
Salvage Therapy
9
2012
139
0.370
Why?
Granulocyte Colony-Stimulating Factor
2
2008
61
0.370
Why?
Mice
19
2024
5719
0.360
Why?
Bone Marrow Transplantation
5
2007
116
0.360
Why?
Enzyme Inhibitors
2
2019
391
0.360
Why?
Membrane Proteins
4
2017
342
0.360
Why?
Ultrasonography, Doppler
2
2007
42
0.350
Why?
Remission Induction
10
2008
207
0.350
Why?
Prospective Studies
9
2019
2344
0.340
Why?
Cell Cycle Proteins
2
2021
166
0.340
Why?
Neoplasm, Residual
4
2022
166
0.340
Why?
Myelodysplastic Syndromes
4
2007
80
0.340
Why?
B-Lymphocytes
4
2021
170
0.330
Why?
Waldenstrom Macroglobulinemia
3
2018
40
0.330
Why?
Immunosuppressive Agents
3
2005
220
0.320
Why?
Lymphoma, B-Cell
3
2021
63
0.320
Why?
Bone Neoplasms
1
2010
179
0.320
Why?
Neovascularization, Pathologic
1
2009
161
0.320
Why?
Brain Diseases, Metabolic
1
2007
5
0.300
Why?
Proteasome Endopeptidase Complex
4
2018
114
0.300
Why?
Monoclonal Gammopathy of Undetermined Significance
3
2023
103
0.300
Why?
Aged, 80 and over
11
2019
3125
0.300
Why?
Hyperammonemia
1
2007
18
0.290
Why?
Chromosome Deletion
3
2008
141
0.290
Why?
Dose-Response Relationship, Drug
6
2016
1374
0.290
Why?
Amyloidosis
2
2007
78
0.290
Why?
Research Design
1
2009
343
0.290
Why?
Farnesyltranstransferase
1
2006
5
0.290
Why?
Thrombophilia
4
2009
18
0.290
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
53
0.290
Why?
Small Molecule Libraries
2
2019
68
0.290
Why?
Hemostasis
1
2007
55
0.280
Why?
Bone and Bones
1
2010
468
0.280
Why?
Sirolimus
1
2006
62
0.270
Why?
Immunotherapy, Adoptive
4
2024
154
0.270
Why?
Gastrointestinal Neoplasms
1
2006
44
0.270
Why?
Cell Survival
8
2018
598
0.270
Why?
Caspases
1
2006
104
0.260
Why?
In Situ Hybridization, Fluorescence
6
2016
252
0.260
Why?
Flow Cytometry
6
2018
470
0.260
Why?
Diploidy
2
2004
26
0.260
Why?
beta 2-Microglobulin
5
2008
38
0.250
Why?
Antibody Formation
1
2005
56
0.250
Why?
Religion
1
2005
63
0.250
Why?
Killer Cells, Natural
3
2012
95
0.250
Why?
Activated Protein C Resistance
4
2011
10
0.250
Why?
Case-Control Studies
10
2018
1128
0.240
Why?
Enoxaparin
1
2004
27
0.240
Why?
Aneuploidy
1
2004
18
0.240
Why?
Ubiquitination
2
2021
43
0.230
Why?
Adaptation, Psychological
1
2005
223
0.230
Why?
Attitude to Health
1
2005
191
0.230
Why?
Osteolysis
2
2022
75
0.230
Why?
Multivariate Analysis
5
2008
585
0.220
Why?
Cancer Vaccines
3
2010
78
0.220
Why?
Cisplatin
6
2009
278
0.220
Why?
Randomized Controlled Trials as Topic
4
2012
553
0.220
Why?
Pyrimidines
3
2015
191
0.220
Why?
Cell Communication
2
2006
69
0.220
Why?
Blood Coagulation
1
2003
57
0.220
Why?
Critical Illness
1
2005
286
0.220
Why?
Mice, Inbred NOD
6
2020
96
0.220
Why?
Antigens, CD34
1
2003
66
0.220
Why?
Cytogenetic Analysis
6
2007
82
0.210
Why?
Graft vs Host Disease
5
2010
74
0.210
Why?
Kidney
1
2007
665
0.210
Why?
Parathyroid Hormone
3
2010
147
0.210
Why?
Leukemia, Myeloid
1
2002
44
0.210
Why?
Cyclophosphamide
4
2003
165
0.210
Why?
STAT3 Transcription Factor
4
2015
81
0.210
Why?
Chromosome Disorders
1
2002
35
0.200
Why?
Bone Resorption
2
2022
303
0.200
Why?
Etoposide
5
2009
72
0.200
Why?
Neoplasms, Second Primary
1
2002
69
0.200
Why?
Time Factors
9
2016
2912
0.200
Why?
Hypothyroidism
1
2002
54
0.200
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
67
0.200
Why?
Antibodies, Bispecific
1
2022
57
0.190
Why?
Logistic Models
5
2018
891
0.190
Why?
Chromosomes, Human, Pair 1
3
2006
93
0.190
Why?
Neoplasm Recurrence, Local
4
2024
618
0.180
Why?
Cytotoxicity, Immunologic
3
2012
54
0.180
Why?
Xenograft Model Antitumor Assays
5
2019
210
0.180
Why?
Neoplasms
2
2009
1233
0.180
Why?
DNA-Binding Proteins
2
2020
436
0.170
Why?
Glucuronidase
2
2018
46
0.170
Why?
Predictive Value of Tests
5
2009
904
0.170
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
129
0.170
Why?
Hematologic Neoplasms
2
2016
99
0.170
Why?
Healthcare Disparities
1
2022
258
0.170
Why?
Syndecan-1
3
2017
72
0.170
Why?
Cytokines
4
2007
612
0.160
Why?
Osteoclasts
4
2022
425
0.160
Why?
Kaplan-Meier Estimate
6
2015
469
0.160
Why?
Hydrocarbons, Aromatic
1
2018
2
0.160
Why?
Solvents
1
2018
29
0.160
Why?
Drug Tolerance
1
2018
60
0.160
Why?
Pyridines
1
2019
130
0.160
Why?
T-Lymphocytes, Cytotoxic
3
2010
65
0.160
Why?
Jehovah's Witnesses
1
2018
6
0.160
Why?
Dendritic Cells
3
2010
132
0.160
Why?
Tumor Microenvironment
2
2023
210
0.160
Why?
Vincristine
3
2003
89
0.160
Why?
Cell Differentiation
4
2022
653
0.150
Why?
Platelet Count
3
2008
72
0.150
Why?
CDC2-CDC28 Kinases
2
2015
12
0.150
Why?
Iron
2
2017
122
0.150
Why?
Risk Assessment
5
2023
1262
0.150
Why?
Occupational Diseases
1
2018
89
0.150
Why?
Arsenicals
2
2010
14
0.150
Why?
Drug Combinations
1
2017
123
0.150
Why?
Pyruvate Kinase
1
2017
7
0.150
Why?
Oxides
2
2010
18
0.150
Why?
Ascorbic Acid
1
2017
24
0.140
Why?
Mice, SCID
5
2018
175
0.140
Why?
Interleukin-6
2
2018
264
0.140
Why?
Occupational Exposure
1
2018
122
0.140
Why?
Anthropometry
1
2017
92
0.140
Why?
RNA Splicing
1
2017
37
0.140
Why?
Glycolysis
1
2017
70
0.140
Why?
Factor V
3
2011
11
0.140
Why?
Immunoglobulin lambda-Chains
1
2016
15
0.140
Why?
Transcription Factors
1
2020
563
0.140
Why?
Immunotherapy
4
2006
238
0.140
Why?
Immunoglobulin kappa-Chains
1
2016
22
0.140
Why?
Incidence
3
2009
1003
0.140
Why?
Fibrinolytic Agents
2
2007
125
0.140
Why?
MicroRNAs
1
2020
354
0.140
Why?
Tumor Cells, Cultured
6
2019
465
0.140
Why?
Leukocytes, Mononuclear
2
2014
116
0.130
Why?
Reproductive History
1
2015
4
0.130
Why?
Oncolytic Virotherapy
1
2015
16
0.130
Why?
Hormone Replacement Therapy
1
2015
27
0.130
Why?
Cyclopentanes
1
2015
10
0.130
Why?
Cell Adhesion Molecules
1
2015
85
0.130
Why?
Ubiquitins
1
2015
39
0.130
Why?
Hemorrhage
2
2007
202
0.130
Why?
Cation Transport Proteins
1
2015
27
0.130
Why?
Receptors, Cell Surface
1
2015
121
0.130
Why?
Aldehyde Dehydrogenase
1
2014
26
0.120
Why?
NF-kappa B
3
2018
314
0.120
Why?
Postmenopause
1
2015
100
0.120
Why?
Drug Monitoring
1
2015
77
0.120
Why?
Intestines
1
2016
176
0.120
Why?
Leukapheresis
1
2014
14
0.120
Why?
Transplantation Chimera
3
2003
15
0.120
Why?
Protein-Tyrosine Kinases
1
2015
95
0.120
Why?
Translocation, Genetic
3
2005
264
0.120
Why?
Myeloma Proteins
2
2020
24
0.120
Why?
Gene Deletion
3
2004
266
0.120
Why?
Antibodies
2
2024
155
0.120
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
23
0.120
Why?
Body Mass Index
1
2017
652
0.110
Why?
Veratrum Alkaloids
1
2013
5
0.110
Why?
Polymorphism, Single Nucleotide
1
2016
485
0.110
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.110
Why?
Isoxazoles
1
2013
14
0.110
Why?
Biopsy
2
2006
582
0.110
Why?
Hedgehog Proteins
1
2013
33
0.110
Why?
Sulfones
1
2013
24
0.110
Why?
Cystatin M
2
2024
20
0.110
Why?
Itraconazole
1
2013
40
0.110
Why?
Metaphase
3
2008
44
0.110
Why?
Genetic Predisposition to Disease
1
2016
510
0.110
Why?
Carrier Proteins
2
2017
304
0.110
Why?
Intercellular Adhesion Molecule-1
1
2013
63
0.110
Why?
B-Cell Maturation Antigen
2
2024
88
0.110
Why?
Wnt Proteins
1
2013
100
0.110
Why?
Renal Insufficiency
3
2009
109
0.110
Why?
Infusions, Intravenous
2
2003
207
0.110
Why?
Risk
2
2011
320
0.110
Why?
Viremia
1
2012
22
0.100
Why?
Drug Delivery Systems
2
2005
136
0.100
Why?
Cytomegalovirus Infections
1
2012
34
0.100
Why?
Chromosomes, Human, Pair 11
2
2002
54
0.100
Why?
Clinical Trials, Phase II as Topic
1
2012
43
0.100
Why?
Clinical Trials, Phase III as Topic
1
2012
43
0.100
Why?
Radiopharmaceuticals
2
2021
209
0.100
Why?
Receptors, KIR
2
2008
13
0.100
Why?
Fluorodeoxyglucose F18
2
2021
191
0.100
Why?
Phosphorylation
2
2020
536
0.100
Why?
Medical Oncology
1
2012
96
0.100
Why?
Alcohol Drinking
1
2013
223
0.100
Why?
Reoperation
2
2004
452
0.100
Why?
Ligands
2
2009
204
0.100
Why?
Inflammation
1
2016
604
0.100
Why?
Drug Evaluation, Preclinical
1
2012
144
0.100
Why?
Age Factors
3
2005
1090
0.100
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
6
0.100
Why?
Tretinoin
2
2009
53
0.090
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
20
0.090
Why?
Smoking
1
2014
510
0.090
Why?
Recombinant Proteins
2
2010
486
0.090
Why?
Antineoplastic Agents, Hormonal
2
2007
47
0.090
Why?
Janus Kinase 1
1
2010
17
0.090
Why?
Macrophages
1
2013
364
0.090
Why?
MAP Kinase Kinase 1
1
2010
23
0.090
Why?
Cyclin-Dependent Kinases
1
2010
28
0.090
Why?
Down-Regulation
2
2010
349
0.090
Why?
Authorship
1
2010
12
0.090
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
83
0.090
Why?
Neoplasm Staging
3
2015
746
0.090
Why?
Conflict of Interest
1
2010
25
0.090
Why?
Drug Industry
1
2010
38
0.090
Why?
Bone Density Conservation Agents
1
2010
77
0.090
Why?
Disclosure
1
2010
38
0.090
Why?
Diphosphonates
1
2010
90
0.090
Why?
Mice, Transgenic
3
2021
555
0.090
Why?
Leukocyte Count
2
2014
70
0.080
Why?
Chromosome Banding
2
2006
24
0.080
Why?
Plasmacytoma
2
2011
42
0.080
Why?
Maximum Tolerated Dose
2
2009
37
0.080
Why?
Periodicals as Topic
1
2010
58
0.080
Why?
Cell Cycle
2
2010
232
0.080
Why?
Oligonucleotide Array Sequence Analysis
5
2014
412
0.080
Why?
Magnetic Resonance Imaging
3
2007
1533
0.080
Why?
Cryoglobulinemia
1
2008
13
0.080
Why?
Blotting, Western
3
2015
602
0.080
Why?
Cytogenetics
1
2008
23
0.080
Why?
Prednisone
2
2009
99
0.080
Why?
Neutrophils
2
2014
137
0.080
Why?
Vascular Endothelial Growth Factor A
1
2009
201
0.080
Why?
Pulmonary Embolism
1
2009
97
0.080
Why?
Sulfonamides
1
2009
129
0.080
Why?
Hemoglobins
1
2008
108
0.080
Why?
Polyethylene Glycols
1
2008
96
0.080
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
595
0.080
Why?
Immunophenotyping
2
2007
109
0.080
Why?
Adoptive Transfer
1
2007
39
0.080
Why?
Heparin, Low-Molecular-Weight
1
2007
20
0.080
Why?
Histocompatibility Antigens Class I
1
2007
44
0.080
Why?
Phlebography
1
2007
62
0.070
Why?
Fibrinolysis
1
2007
5
0.070
Why?
Ammonia
1
2007
71
0.070
Why?
Blood Coagulation Factors
1
2007
17
0.070
Why?
Serum Albumin
2
2008
58
0.070
Why?
Chi-Square Distribution
1
2007
282
0.070
Why?
Biomedical Research
1
2010
231
0.070
Why?
Brain
2
2007
1309
0.070
Why?
Cell Membrane
1
2007
248
0.070
Why?
Osteoprotegerin
1
2006
52
0.070
Why?
Drug Administration Schedule
2
2006
376
0.070
Why?
Models, Genetic
1
2006
174
0.070
Why?
Guanosine
1
2006
6
0.070
Why?
Antibiotics, Antineoplastic
1
2006
78
0.070
Why?
Sex Factors
3
2016
693
0.070
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Renal Dialysis
1
2007
169
0.060
Why?
Neovascularization, Physiologic
1
2005
67
0.060
Why?
Survivors
1
2006
124
0.060
Why?
Guanosine Triphosphate
1
2004
19
0.060
Why?
Karyotyping
1
2005
83
0.060
Why?
Gene Duplication
1
2005
15
0.060
Why?
Oncogene Proteins, Fusion
1
2005
57
0.060
Why?
Tissue Donors
2
2003
111
0.060
Why?
Kidney Transplantation
1
2007
175
0.060
Why?
Proteolysis
2
2015
94
0.060
Why?
Thrombophlebitis
1
2004
24
0.060
Why?
Genomic Instability
1
2005
92
0.060
Why?
Tomography, Emission-Computed
1
2004
53
0.060
Why?
Ferritins
1
2024
29
0.060
Why?
RNA Interference
2
2015
179
0.060
Why?
Myeloid Progenitor Cells
1
2023
18
0.060
Why?
X-Ray Microtomography
1
2024
76
0.060
Why?
Patient Selection
1
2005
251
0.060
Why?
Chromatography, High Pressure Liquid
1
2004
349
0.060
Why?
Discitis
1
2003
9
0.060
Why?
Anxiety
1
2005
269
0.060
Why?
Stem Cell Factor
1
2003
7
0.060
Why?
Confidence Intervals
1
2003
156
0.060
Why?
Lymphocyte Transfusion
1
2003
10
0.060
Why?
Probability
1
2003
164
0.060
Why?
Neoplastic Cells, Circulating
1
2004
73
0.060
Why?
Interferons
1
2002
40
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
146
0.050
Why?
Cyclosporine
1
2003
64
0.050
Why?
Drug Therapy, Combination
2
2017
378
0.050
Why?
Geography
1
2022
61
0.050
Why?
Tacrolimus
1
2003
51
0.050
Why?
Thyroid Function Tests
1
2002
24
0.050
Why?
Blood Group Incompatibility
1
2002
5
0.050
Why?
Administration, Oral
1
2003
423
0.050
Why?
Stromal Cells
1
2002
72
0.050
Why?
ABO Blood-Group System
1
2002
15
0.050
Why?
Thyrotropin
1
2002
47
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.050
Why?
Drug Interactions
1
2002
206
0.050
Why?
Fatal Outcome
1
2002
195
0.050
Why?
Cell Division
1
2002
292
0.050
Why?
Chromosome Mapping
3
2006
160
0.050
Why?
Genomics
1
2023
282
0.050
Why?
Graft Survival
1
2002
152
0.050
Why?
RANK Ligand
1
2022
179
0.050
Why?
Acute Disease
1
2002
369
0.050
Why?
Cells, Cultured
1
2005
1571
0.050
Why?
Young Adult
3
2015
3935
0.050
Why?
Cluster Analysis
3
2006
235
0.050
Why?
Tomography, X-Ray Computed
1
2006
1159
0.050
Why?
Depression
1
2005
564
0.050
Why?
Neoplasm Transplantation
1
2020
85
0.050
Why?
Odds Ratio
2
2016
548
0.040
Why?
3' Untranslated Regions
1
2020
52
0.040
Why?
Pain
1
2003
380
0.040
Why?
Postoperative Complications
1
2007
1000
0.040
Why?
Staphylococcal Infections
1
2003
269
0.040
Why?
Positron-Emission Tomography
1
2021
294
0.040
Why?
Crystallography, X-Ray
1
2019
147
0.040
Why?
Antigens, CD
2
2015
215
0.040
Why?
Protein Conformation
1
2019
166
0.040
Why?
Mice, Nude
1
2019
252
0.040
Why?
Coculture Techniques
2
2012
146
0.040
Why?
Bone Marrow Cells
2
2015
192
0.040
Why?
Mice, Inbred BALB C
1
2019
303
0.040
Why?
Receptors, Interleukin-6
1
2018
22
0.040
Why?
Antigens, CD19
1
2018
24
0.040
Why?
Drug Resistance
1
2018
63
0.040
Why?
Microarray Analysis
1
2018
73
0.040
Why?
Disease Management
1
2020
174
0.040
Why?
Interferon-gamma
2
2010
174
0.040
Why?
Protein Stability
1
2018
43
0.040
Why?
Gene Knockdown Techniques
1
2018
106
0.040
Why?
Epidemiologic Methods
2
2008
49
0.040
Why?
Aerobiosis
1
2017
13
0.040
Why?
Cross-Sectional Studies
1
2022
1541
0.040
Why?
Microfilament Proteins
1
2017
43
0.040
Why?
Thyroid Hormones
1
2017
18
0.040
Why?
HLA-A Antigens
2
2007
10
0.040
Why?
Vaccination
2
2010
268
0.040
Why?
Calcium-Binding Proteins
1
2017
54
0.040
Why?
Transplantation, Heterologous
1
2017
74
0.040
Why?
Polycomb Repressive Complex 1
1
2016
3
0.040
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.040
Why?
Proto-Oncogene Proteins c-myc
1
2017
50
0.040
Why?
Genetic Loci
1
2016
49
0.030
Why?
Protein Binding
1
2018
660
0.030
Why?
Antibodies, Neoplasm
2
2006
28
0.030
Why?
Mice, Inbred ICR
1
2016
21
0.030
Why?
Mice, Knockout
1
2018
841
0.030
Why?
Microscopy, Electron, Transmission
1
2015
74
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Genome-Wide Association Study
1
2016
166
0.030
Why?
ras Proteins
1
2015
64
0.030
Why?
Tumor Burden
1
2016
132
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Repressor Proteins
1
2016
151
0.030
Why?
RNA, Messenger
2
2010
1105
0.030
Why?
Lentivirus
1
2015
16
0.030
Why?
Disease Models, Animal
2
2013
1451
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
Family
1
2016
169
0.030
Why?
Molecular Targeted Therapy
1
2016
119
0.030
Why?
Adenine
1
2015
32
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
7
0.030
Why?
Reactive Oxygen Species
1
2017
408
0.030
Why?
Models, Biological
1
2018
728
0.030
Why?
CDC2 Protein Kinase
1
2014
15
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cell Lineage
1
2014
84
0.030
Why?
Mitosis
1
2014
92
0.030
Why?
Drug Synergism
1
2014
150
0.030
Why?
Piperidines
1
2015
97
0.030
Why?
beta Catenin
1
2015
102
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
136
0.030
Why?
Pyrazoles
1
2015
113
0.030
Why?
Cell Movement
1
2015
247
0.030
Why?
Proportional Hazards Models
2
2006
406
0.030
Why?
Patient Safety
1
2014
101
0.030
Why?
Peptide Library
1
2013
16
0.030
Why?
Receptors, IgG
1
2013
22
0.030
Why?
Adolescent
2
2014
6339
0.030
Why?
Chromosomal Instability
1
2013
16
0.030
Why?
Epitopes
1
2013
59
0.030
Why?
Membrane Glycoproteins
2
2006
240
0.030
Why?
Protein Kinase Inhibitors
1
2014
202
0.030
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
47
0.030
Why?
Immunoglobulin M
1
2012
52
0.030
Why?
Cytomegalovirus
1
2012
26
0.030
Why?
Interleukin Receptor Common gamma Subunit
1
2012
8
0.030
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
9
0.030
Why?
Viral Load
1
2012
76
0.030
Why?
Virus Activation
1
2012
32
0.030
Why?
Interleukin-2
1
2012
72
0.030
Why?
Peripheral Nervous System Diseases
1
2012
57
0.030
Why?
Immunoenzyme Techniques
1
2012
143
0.030
Why?
Arkansas
2
2008
1967
0.030
Why?
Viper Venoms
1
2011
7
0.020
Why?
Asymptomatic Diseases
1
2011
36
0.020
Why?
Neoadjuvant Therapy
1
2012
115
0.020
Why?
Protein C
1
2011
18
0.020
Why?
Lymphocyte Activation
1
2012
172
0.020
Why?
Chemotherapy, Adjuvant
1
2011
121
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
22
0.020
Why?
Antiviral Agents
1
2012
174
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
21
0.020
Why?
Interleukin-4
1
2010
43
0.020
Why?
Adjuvants, Immunologic
1
2010
51
0.020
Why?
Immunity, Cellular
1
2010
69
0.020
Why?
Diagnosis, Differential
2
2004
1036
0.020
Why?
Mutation
1
2015
1293
0.020
Why?
Physician's Role
1
2010
48
0.020
Why?
RNA, Small Interfering
1
2010
215
0.020
Why?
Practice Guidelines as Topic
1
2012
448
0.020
Why?
Education, Medical, Continuing
1
2010
68
0.020
Why?
Hyperhomocysteinemia
1
2009
29
0.020
Why?
Protein Isoforms
1
2009
119
0.020
Why?
Indazoles
1
2009
47
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
28
0.020
Why?
Algorithms
1
2012
616
0.020
Why?
Safety
1
2009
78
0.020
Why?
Vasculitis
1
2008
28
0.020
Why?
Ploidies
1
2008
11
0.020
Why?
Haplotypes
1
2008
83
0.020
Why?
Double-Blind Method
1
2009
674
0.020
Why?
Twins
1
2007
33
0.020
Why?
Age Distribution
1
2007
170
0.020
Why?
C-Reactive Protein
1
2008
142
0.020
Why?
Creatinine
1
2007
140
0.020
Why?
Multigene Family
1
2006
56
0.020
Why?
Blood Proteins
1
2007
82
0.020
Why?
CD8-Positive T-Lymphocytes
1
2007
115
0.020
Why?
Partial Thromboplastin Time
1
2006
12
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
34
0.020
Why?
Heterozygote
1
2006
82
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
RNA, Neoplasm
1
2006
44
0.020
Why?
Proteoglycans
1
2006
80
0.020
Why?
Amiloride
1
2005
8
0.020
Why?
HLA-A2 Antigen
1
2005
11
0.020
Why?
Transduction, Genetic
1
2005
45
0.020
Why?
Leukemia, Myeloid, Acute
1
2007
183
0.020
Why?
Cell Line
1
2008
1002
0.020
Why?
Radiography
1
2007
489
0.020
Why?
Data Interpretation, Statistical
1
2006
157
0.020
Why?
Neoplasms, Experimental
1
2006
114
0.020
Why?
Sensitivity and Specificity
1
2007
854
0.020
Why?
Interferon-alpha
1
2005
47
0.020
Why?
Monocytes
1
2005
132
0.020
Why?
Databases, Factual
1
2007
664
0.010
Why?
Clone Cells
1
2004
74
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
222
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Fibroblasts
1
2005
343
0.010
Why?
Trisomy
1
2003
31
0.010
Why?
History, 21st Century
1
2003
57
0.010
Why?
History, 20th Century
1
2003
100
0.010
Why?
Interphase
1
2003
10
0.010
Why?
Plasmapheresis
1
2003
11
0.010
Why?
Back Pain
1
2003
39
0.010
Why?
United States
1
2013
4838
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
9
0.010
Why?
Perforin
1
2002
11
0.010
Why?
Anemia
1
2003
68
0.010
Why?
Antigen Presentation
1
2002
25
0.010
Why?
Cohort Studies
1
2006
1422
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Prevalence
1
2005
943
0.010
Why?
Quality Assurance, Health Care
1
2003
149
0.010
Why?
Erythrocyte Transfusion
1
2002
46
0.010
Why?
Cell Culture Techniques
1
2002
99
0.010
Why?
DNA, Neoplasm
1
2002
147
0.010
Why?
Graft Rejection
1
2002
159
0.010
Why?
Kidney Diseases
1
2003
214
0.010
Why?
Anti-Bacterial Agents
1
2003
743
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description